Sensitivity analysis of lymphoma risk when individual studies were excluded from the analysis
| Study excluded | SIR (95% CI) | Test of heterogeneity p value* |
|---|---|---|
| SIR, standardised incidence ratio (expected/observed). | ||
| *p<0.05 implies there is significant heterogeneity among the studies included in the analysis. | ||
| Connell14 | 5.21 (2.59–9.35) | 0.09 |
| Kinlen12 | 3.64 (1.65–6.94) | 0.03 |
| Farrell15 | 3.49 (1.58–6.66) | 0.12 |
| Lewis1 | 5.02 (2.39–9.27) | 0.03 |
| Fraser 16 | 4.03 (1.72–7.98) | 0.01 |
| Korelitz17 | 3.95 (1.69–7.84) | 0.01 |